Darlene Guillen
Instituto de Oncología de Rosario(AR)
Publications by Year
Research Areas
Lysosomal Storage Disorders Research, Trypanosoma species research and implications, Glycogen Storage Diseases and Myoclonus, T-cell and B-cell Immunology, Autism Spectrum Disorder Research
Most-Cited Works
- → Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice(2012)93 cited
- → The Pharmacological Chaperone AT2220 Increases Recombinant Human Acid α-Glucosidase Uptake and Glycogen Reduction in a Mouse Model of Pompe Disease(2012)83 cited
- Mapping and binding analysis of peptides derived from the tumor-associated antigen survivin for eight HLA alleles.(2005)
- → Characterization of Antibodies to CA 125 that Bind Preferentially to the Cell-Associated Form of the Antigen(2006)8 cited
- → Exploring the Use of Pharmacological Chaperone AT3375 Alone and in Combination with Recombinant human ß-Glucosidase for Gaucher Disease(2012)3 cited
- → EP01.01-27 Gender and Lung Cancer (LC): Preliminary Data from a Prospective, Woman-Centered Local Registry(2023)
- → Antitumor Monoclonal Antibodies Generated by Immunization with Mucins(1991)
- → The Effect of Soluble P-Selectin in Coagulation(2008)
- → T.P.44 The pharmacological chaperone AT2220 increases the stability of recombinant human acid α-glucosidase and leads to greater tissue uptake and glycogen reduction in a mouse model of Pompe disease(2012)
- → O2‐04‐05: A cell‐based model for presenilin 1 early‐onset familial Alzheimer's disease (EOFAD): Dominant negative effects and relative stabilities of presenilin 1 with EOFAD mutations(2012)